Skip to main navigation Skip to search Skip to main content

Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial

  • Satish K. Garg
  • , George Grunberger
  • , Ruth Weinstock
  • , Margaret L. Lawson
  • , Irl B. Hirsch
  • , Linda A. Dimeglio
  • , Rodica Pop-Busui
  • , Athena Philis-Tsimikas
  • , Mark Kipnes
  • , David R. Liljenquist
  • , Ronald L. Brazg
  • , Yogish C. Kudva
  • , Bruce A. Buckingham
  • , Janet B. McGill
  • , Anders L. Carlson
  • , Amy B. Criego
  • , Mark P. Christiansen
  • , Kevin B. Kaiserman
  • , Kurt J. Griffin
  • , Greg P. Forlenza
  • Bruce W. Bode, Robert H. Slover, Ashleigh Keiter, Chenxiao Ling, Briggitte Marinos, Toni L. Cordero, John Shin, Scott W. Lee, Andrew S. Rhinehart, Robert A. Vigersky

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalDiabetes Technology and Therapeutics
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Keywords

  • A1C
  • Adult
  • Diabetes treatment satisfaction
  • Hybrid closed loop
  • Pediatric
  • Time below range
  • Time in range
  • Type 1 diabetes
  • Humans
  • Middle Aged
  • Child, Preschool
  • Blood Glucose
  • Glycated Hemoglobin
  • Diabetic Ketoacidosis/drug therapy
  • Young Adult
  • Diabetes Mellitus, Type 1/drug therapy
  • Adolescent
  • Blood Glucose Self-Monitoring
  • Aged, 80 and over
  • Hypoglycemic Agents/therapeutic use
  • Insulin Infusion Systems
  • Aged
  • Child
  • Insulin/therapeutic use

Cite this